Webinar
Contents
Chair(s)

Prof. Guido Guenther Heinrich Gerken
Department of Gastroenterology and Hepatology, University of Essen, Essen, Germany.

Prof. Giuliano Ramadori
University Medical Center Göttingen, Göttingen, Germany.
Speaker(s)

Pierluigi Toniutto
Department of Specialized Medicine, Hepatology Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata of Udine, Udine, Italy.
Topic: Risk factors for HCC recurrence after liver transplantation
Topic: Risk factors for HCC recurrence after liver transplantation

Francesco Tovoli
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Topic: Hepatocellular carcinoma in non cirhhotic liver
Topic: Hepatocellular carcinoma in non cirhhotic liver

Dar-In Tai
Liver Research Center, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.
Topic: The role of genetic factors in HBV-related HCC: perspectives from local genetic backgrounds and clinical epidemiology
Topic: The role of genetic factors in HBV-related HCC: perspectives from local genetic backgrounds and clinical epidemiology

Thomas Kietzmann
University of Oulu, Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, Oulu, Finland.
Topic: Metabolic zonation in normal and cirrhotic liver
Topic: Metabolic zonation in normal and cirrhotic liver

Jin-Wook Kim
Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Topic: Reappraisal of HCC surveillance in chronic HBV infection: need for risk stratification
Topic: Reappraisal of HCC surveillance in chronic HBV infection: need for risk stratification

John Koskinas
Department of Internal Medicine, Medical School of Athens, Hippokration Hospital, Athens, Greece.
Topic: Beta-talassemia and HCC: what is the etiology?
Topic: Beta-talassemia and HCC: what is the etiology?

Jan Best
Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Topic: Use of GALAD score in the early diagnostic and treatment follow up of HCC
Topic: Use of GALAD score in the early diagnostic and treatment follow up of HCC
Relevant Special Issue(s)

Research on the Risk Factors of Liver Cirrhosis Complicated with HCC
https://www.oaepublish.com/specials/hr.334Moments





